These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 32394495

  • 1. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented.
    Pate A, Elliott RA, Gkountouras G, Thompson A, Emsley R, van Staa T.
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):644-652. PubMed ID: 32394495
    [Abstract] [Full Text] [Related]

  • 2. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
    Zhao B, He X, Wu J, Yan S.
    BMC Cardiovasc Disord; 2020 Jun 10; 20(1):282. PubMed ID: 32522146
    [Abstract] [Full Text] [Related]

  • 3. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
    Yebyo HG, Zappacosta S, Aschmann HE, Haile SR, Puhan MA.
    BMC Cardiovasc Disord; 2020 Sep 17; 20(1):418. PubMed ID: 32942999
    [Abstract] [Full Text] [Related]

  • 4. Inception and deprescribing of statins in people aged over 80 years: cohort study.
    Gulliford M, Ravindrarajah R, Hamada S, Jackson S, Charlton J.
    Age Ageing; 2017 Nov 01; 46(6):1001-1005. PubMed ID: 29088364
    [Abstract] [Full Text] [Related]

  • 5. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018).
    Liu Y, Lv X, Xie N, Fang Z, Ren W, Gong Y, Jin Y, Zhang J.
    BMC Cardiovasc Disord; 2020 Apr 25; 20(1):201. PubMed ID: 32334525
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.
    Malmborg M, Schmiegelow MDS, Gerds T, Schou M, Kistorp C, Torp-Pedersen C, Gislason G.
    J Am Heart Assoc; 2021 Jul 06; 10(13):e020395. PubMed ID: 34151606
    [Abstract] [Full Text] [Related]

  • 10. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
    Vinogradova Y, Coupland C, Brindle P, Hippisley-Cox J.
    BMJ; 2016 Jun 28; 353():i3305. PubMed ID: 27353261
    [Abstract] [Full Text] [Related]

  • 11. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.
    Lavikainen P, Helin-Salmivaara A, Eerola M, Fang G, Hartikainen J, Huupponen R, Korhonen MJ.
    BMJ Open; 2016 Jun 03; 6(6):e011306. PubMed ID: 27259530
    [Abstract] [Full Text] [Related]

  • 12. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
    Sofat S, Chen X, Chowdhury MM, Coughlin PA.
    Eur J Vasc Endovasc Surg; 2021 Sep 03; 62(3):450-461. PubMed ID: 34389230
    [Abstract] [Full Text] [Related]

  • 13. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N, Henrard S, van den Akker M, Goderis G, Buntinx F, Van Pottelbergh G, Vaes B.
    BMC Cardiovasc Disord; 2018 Nov 06; 18(1):209. PubMed ID: 30400778
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.
    Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Schmidt TA, Saely CH, Baumgartner I, Tamargo J.
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct 01; 4(4):230-236. PubMed ID: 30099530
    [Abstract] [Full Text] [Related]

  • 19. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
    Rannanheimo PK, Tiittanen P, Hartikainen J, Helin-Salmivaara A, Huupponen R, Vahtera J, Korhonen MJ.
    Value Health; 2015 Sep 01; 18(6):896-905. PubMed ID: 26409618
    [Abstract] [Full Text] [Related]

  • 20. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T, Zhou S, Anzalone D, Kern DM, Tunceli O, Cziraky MJ, Willey VJ.
    J Am Heart Assoc; 2017 May 04; 6(5):. PubMed ID: 28473405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.